Correlation Between Amicus Therapeutics and Artelo Biosciences

Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amicus Therapeutics and Artelo Biosciences, you can compare the effects of market volatilities on Amicus Therapeutics and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Artelo Biosciences.

Diversification Opportunities for Amicus Therapeutics and Artelo Biosciences

-0.09

Correlation Coefficient

Amicus Therapeutics  Artelo Biosciences

Good diversification

The 3 months correlation between Amicus and Artelo is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Artelo Biosciences go up and down completely randomly.

Pair Corralation between Amicus Therapeutics and Artelo Biosciences

Given the investment horizon of 90 days Amicus Therapeutics is expected to under-perform the Artelo Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Amicus Therapeutics is 2.07 times less risky than Artelo Biosciences. The stock trades about -0.03 of its potential returns per unit of risk. The Artelo Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  107.00  in Artelo Biosciences on December 1, 2024 and sell it today you would earn a total of  0.00  from holding Artelo Biosciences or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Amicus Therapeutics  vs.  Artelo Biosciences

Amicus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Amicus Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Artelo Biosciences

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Artelo Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Artelo Biosciences is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Amicus Therapeutics and Artelo Biosciences

The main advantage of trading using opposite Amicus Therapeutics and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.

The idea behind Amicus Therapeutics and Artelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.